InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Olivier Soula, Chief Executive Officer. Director active across 1 companies, notably ADOCIA. In total, 1 reports have been published. Total volume traded: €150k. The latest transaction was disclosed on 21 March 2024 — Acquisition. Regulator: AMF. All data is accessible without signup.
Declarations1 total
€149,99715,576 shares@ €9.630.16% mcap100.0% of flow
ActionEuronext Paris
2024DD958565·
Ideal exit: 16 Dec 2024 (T+270)
1 of 1 declaration
About Olivier Soula
Olivier Soula is the Chief Executive Officer of ADOCIA, a company focused on developing innovative treatments for diabetes and other metabolic diseases. Under his leadership, ADOCIA is committed to improving patients' lives through advanced therapeutic solutions. Olivier Soula has extensive experience in the pharmaceutical and biopharmaceutical sectors, enabling him to guide the company towards new heights of innovation and growth.
